{"transactions":[{"id":750064,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:11:35.000Z","date":"2026-06-03","kind":"exercise","planned":false,"acquired":false,"shares":89312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":89312},"source":{"system":"sec-edgar","filing":"0001062822-26-000104","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000104/form4.xml","form_type":"4"}},{"id":750063,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-04T20:11:35.000Z","date":"2026-06-03","kind":"exercise","planned":false,"acquired":true,"shares":89312,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":213771,"source":{"system":"sec-edgar","filing":"0001062822-26-000104","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000104/form4.xml","form_type":"4"}},{"id":794409,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-04T20:32:01.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":43478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":43478,"derivative":{"exercise_price":1.61,"expiration_date":"2036-05-01","underlying":"Common Stock","underlying_shares":43478},"source":{"system":"sec-edgar","filing":"0001062822-26-000084","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000084/form4.xml","form_type":"4"}},{"id":794408,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-05-04T20:32:01.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":35714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":35714,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":35714},"source":{"system":"sec-edgar","filing":"0001062822-26-000084","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000084/form4.xml","form_type":"4"}},{"id":1125932,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-06-03T20:22:03.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":89312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":89312,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":89312},"source":{"system":"sec-edgar","filing":"0001127602-25-016465","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225016465/form4.xml","form_type":"4"}},{"id":1125931,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-03T20:22:03.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":103806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":103806,"derivative":{"exercise_price":0.6216,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":103806},"source":{"system":"sec-edgar","filing":"0001127602-25-016465","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225016465/form4.xml","form_type":"4"}},{"id":1151232,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-05-13T21:50:10.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":false,"shares":36810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":36810},"source":{"system":"sec-edgar","filing":"0001127602-25-014143","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225014143/form4.xml","form_type":"4"}},{"id":1151231,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-13T21:50:10.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":true,"shares":36810,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":124459,"source":{"system":"sec-edgar","filing":"0001127602-25-014143","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225014143/form4.xml","form_type":"4"}},{"id":1519504,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-05-13T20:01:32.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":36810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":36810,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":36810},"source":{"system":"sec-edgar","filing":"0001127602-24-015077","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224015077/form4.xml","form_type":"4"}},{"id":1519503,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-13T20:01:32.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":44906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":44906,"derivative":{"exercise_price":1.79,"expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":44906},"source":{"system":"sec-edgar","filing":"0001127602-24-015077","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224015077/form4.xml","form_type":"4"}},{"id":1534029,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-04-29T20:17:09.000Z","date":"2024-04-28","kind":"exercise","planned":false,"acquired":false,"shares":8032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8032},"source":{"system":"sec-edgar","filing":"0001127602-24-013554","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224013554/form4.xml","form_type":"4"}},{"id":1534028,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-29T20:17:09.000Z","date":"2024-04-28","kind":"exercise","planned":false,"acquired":true,"shares":8032,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":87649,"source":{"system":"sec-edgar","filing":"0001127602-24-013554","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224013554/form4.xml","form_type":"4"}},{"id":1839975,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-07-03T20:57:54.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":42438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":42438,"derivative":{"exercise_price":0.5891,"exercise_date":"2024-06-30","expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":42438},"source":{"system":"sec-edgar","filing":"0001104659-23-077660","document":"tm2320411-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077660/tm2320411-8_4seq1.xml","form_type":"4"}},{"id":1839974,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-03T20:57:54.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":21219,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 21,219 restricted stock units on June 30, 2023, which shall vest in full on June 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":40415,"source":{"system":"sec-edgar","filing":"0001104659-23-077660","document":"tm2320411-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465923077660/tm2320411-8_4seq1.xml","form_type":"4"}},{"id":1883114,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-05-22T20:02:55.000Z","date":"2023-05-21","kind":"exercise","planned":false,"acquired":false,"shares":9302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9302},"source":{"system":"sec-edgar","filing":"0001127602-23-016430","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223016430/form4.xml","form_type":"4"}},{"id":1883113,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-22T20:02:55.000Z","date":"2023-05-21","kind":"exercise","planned":false,"acquired":true,"shares":9302,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":79617,"source":{"system":"sec-edgar","filing":"0001127602-23-016430","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223016430/form4.xml","form_type":"4"}},{"id":1911573,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-28T20:22:03.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":12658,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":12658,"derivative":{"exercise_price":2.36,"expiration_date":"2033-04-28","underlying":"Common Stock","underlying_shares":12658},"source":{"system":"sec-edgar","filing":"0001127602-23-013781","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223013781/form4.xml","form_type":"4"}},{"id":1911572,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-04-28T20:22:03.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":8032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":8032,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8032},"source":{"system":"sec-edgar","filing":"0001127602-23-013781","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223013781/form4.xml","form_type":"4"}},{"id":2230351,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T20:10:40.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":31645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These options were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":31645,"derivative":{"exercise_price":1.11,"exercise_date":"2023-06-14","expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":31645},"source":{"system":"sec-edgar","filing":"0001104659-22-071892","document":"tm2218645-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465922071892/tm2218645-1_4seq1.xml","form_type":"4"}},{"id":2230350,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-16T20:10:40.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":15822,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 15,822 restricted stock units on June 14, 2022, which shall vest in full on June 14, 2023."}],"balance_after":19196,"source":{"system":"sec-edgar","filing":"0001104659-22-071892","document":"tm2218645-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465922071892/tm2218645-1_4seq1.xml","form_type":"4"}},{"id":2260524,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-05-23T20:13:15.000Z","date":"2022-05-21","kind":"grant","acquired":true,"shares":9302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":9302,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9302},"source":{"system":"sec-edgar","filing":"0001127602-22-015367","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222015367/form4.xml","form_type":"4"}},{"id":2260523,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-23T20:13:15.000Z","date":"2022-05-21","kind":"grant","acquired":true,"shares":14402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":14402,"derivative":{"exercise_price":1.77,"expiration_date":"2032-05-21","underlying":"Common Stock","underlying_shares":14402},"source":{"system":"sec-edgar","filing":"0001127602-22-015367","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222015367/form4.xml","form_type":"4"}},{"id":2286814,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-05-02T20:12:48.000Z","date":"2022-04-30","kind":"exercise","acquired":false,"shares":4024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4024},"source":{"system":"sec-edgar","filing":"0001127602-22-012825","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222012825/form4.xml","form_type":"4"}},{"id":2286813,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-02T20:12:48.000Z","date":"2022-04-30","kind":"exercise","acquired":true,"shares":4024,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":70315,"source":{"system":"sec-edgar","filing":"0001127602-22-012825","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222012825/form4.xml","form_type":"4"}},{"id":2489292,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-02T21:07:27.000Z","date":"2021-11-30","kind":"sale","acquired":false,"shares":12,"price":3.5716,"value":42.8592,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person sold 12 shares of common stock on November 30, 2021."}],"balance_after":3374,"source":{"system":"sec-edgar","filing":"0001104659-21-145913","document":"tm2134438-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921145913/tm2134438-1_4seq1.xml","form_type":"4"}},{"id":2591141,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-25T20:16:27.000Z","date":"2021-08-24","kind":"purchase","acquired":true,"shares":1000,"price":5,"value":5000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person purchased 1,000 shares of common stock on August 24, 2021."}],"balance_after":3386,"source":{"system":"sec-edgar","filing":"0001104659-21-109337","document":"tm2125937-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921109337/tm2125937-1_4seq1.xml","form_type":"4"}},{"id":2664335,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T20:08:23.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":4748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These options were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":4748,"derivative":{"exercise_price":6.69,"exercise_date":"2022-06-15","expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":4748},"source":{"system":"sec-edgar","filing":"0001104659-21-082604","document":"tm2119990d6_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921082604/tm2119990d6_4.xml","form_type":"4"}},{"id":2664334,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-17T20:08:23.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":2374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person received an award of 2,374 restricted stock units on June 15, 2021, which shall vest in full on June 15, 2022."}],"balance_after":2386,"source":{"system":"sec-edgar","filing":"0001104659-21-082604","document":"tm2119990d6_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465921082604/tm2119990d6_4.xml","form_type":"4"}},{"id":2733357,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-03T21:02:59.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":6475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":6475,"derivative":{"exercise_price":5.04,"expiration_date":"2031-04-30","underlying":"Common Stock","underlying_shares":6475},"source":{"system":"sec-edgar","filing":"0001127602-21-014962","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014962/form4.xml","form_type":"4"}},{"id":2733356,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-05-03T21:02:59.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":4024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":4024,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4024},"source":{"system":"sec-edgar","filing":"0001127602-21-014962","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014962/form4.xml","form_type":"4"}},{"id":2738786,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-04-27T20:46:36.000Z","date":"2021-04-24","kind":"exercise","acquired":false,"shares":10638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10638},"source":{"system":"sec-edgar","filing":"0001127602-21-014518","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014518/form4.xml","form_type":"4"}},{"id":2738785,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-04-27T20:46:36.000Z","date":"2021-04-24","kind":"exercise","acquired":true,"shares":10638,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":66291,"source":{"system":"sec-edgar","filing":"0001127602-21-014518","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014518/form4.xml","form_type":"4"}},{"id":3097775,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-29T22:48:42.000Z","date":"2020-06-25","kind":"grant","acquired":true,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These options were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":5200,"derivative":{"exercise_price":4.7,"exercise_date":"2021-06-25","expiration_date":"2030-06-25","underlying":"Common Stock","underlying_shares":5200},"source":{"system":"sec-edgar","filing":"0001104659-20-078120","document":"tm2023597d2_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000110465920078120/tm2023597d2_form4.xml","form_type":"4"}},{"id":3169447,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2020-04-27T20:44:44.000Z","date":"2020-04-26","kind":"exercise","acquired":false,"shares":3466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3466},"source":{"system":"sec-edgar","filing":"0001127602-20-014562","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014562/form4.xml","form_type":"4"}},{"id":3169446,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2020-04-27T20:44:44.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":10638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":10638,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10638},"source":{"system":"sec-edgar","filing":"0001127602-20-014562","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014562/form4.xml","form_type":"4"}},{"id":3169445,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-27T20:44:44.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":18115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":18115,"derivative":{"exercise_price":1.86,"expiration_date":"2030-04-24","underlying":"Common Stock","underlying_shares":18115},"source":{"system":"sec-edgar","filing":"0001127602-20-014562","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014562/form4.xml","form_type":"4"}},{"id":3169444,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-04-27T20:44:44.000Z","date":"2020-04-26","kind":"exercise","acquired":true,"shares":3466,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":55653,"source":{"system":"sec-edgar","filing":"0001127602-20-014562","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014562/form4.xml","form_type":"4"}},{"id":3449769,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-08-02T20:12:12.000Z","date":"2019-08-02","kind":"purchase","acquired":true,"shares":12000,"price":1.18,"value":14160.0,"ownership":{"direct":true},"balance_after":52187,"source":{"system":"sec-edgar","filing":"0001127602-19-025862","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219025862/form4.xml","form_type":"4"}},{"id":3449768,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-08-02T20:12:12.000Z","date":"2019-08-02","kind":"purchase","acquired":true,"shares":12000,"price":1.17,"value":14040.0,"ownership":{"direct":true},"balance_after":40187,"source":{"system":"sec-edgar","filing":"0001127602-19-025862","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219025862/form4.xml","form_type":"4"}},{"id":3506591,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-31T20:36:15.000Z","date":"2019-05-29","kind":"grant","acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These options were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":18750,"derivative":{"exercise_price":0.64,"exercise_date":"2020-05-29","expiration_date":"2029-05-29","underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001144204-19-029254","document":"tv522819_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000114420419029254/tv522819_form4.xml","form_type":"4"}},{"id":3546811,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-04-29T21:01:54.000Z","date":"2019-04-26","kind":"grant","acquired":true,"shares":3466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":3466,"derivative":{"underlying":"Common Stock","underlying_shares":3466},"source":{"system":"sec-edgar","filing":"0001127602-19-016490","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219016490/form4.xml","form_type":"4"}},{"id":3546810,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-29T21:01:54.000Z","date":"2019-04-26","kind":"grant","acquired":true,"shares":6519,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":6519,"derivative":{"exercise_price":5.67,"expiration_date":"2029-04-26","underlying":"Common Stock","underlying_shares":6519},"source":{"system":"sec-edgar","filing":"0001127602-19-016490","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219016490/form4.xml","form_type":"4"}},{"id":3908772,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-04T21:32:26.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":8576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These options were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":8576,"derivative":{"exercise_price":1.42,"exercise_date":"2019-05-31","expiration_date":"2028-05-31","underlying":"Common Stock","underlying_shares":8576},"source":{"system":"sec-edgar","filing":"0001144204-18-032715","document":"tv495793_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000114420418032715/tv495793_form4.xml","form_type":"4"}},{"id":3955197,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-27T21:36:21.000Z","date":"2018-04-27","kind":"grant","acquired":true,"shares":2857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 1/12th of the shares subject to the option for each month of service following the date of grant."}],"balance_after":2857,"derivative":{"exercise_price":7.8,"expiration_date":"2028-04-27","underlying":"Common Stock","underlying_shares":2857},"source":{"system":"sec-edgar","filing":"0001127602-18-015441","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218015441/form4.xml","form_type":"4"}},{"id":3955196,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-04-27T21:36:21.000Z","date":"2018-04-27","kind":"grant","acquired":true,"shares":2564,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":28187,"source":{"system":"sec-edgar","filing":"0001127602-18-015441","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218015441/form4.xml","form_type":"4"}},{"id":4207432,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-09-18T10:36:48.000Z","date":"2017-09-15","kind":"purchase","acquired":true,"shares":1000,"price":12.5,"value":12500.0,"ownership":{"direct":true},"balance_after":25623,"source":{"system":"sec-edgar","filing":"0001127602-17-027538","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217027538/form4.xml","form_type":"4"}},{"id":4298379,"issuer":{"id":8225,"kind":"organization","name":"Bio Green Med Solution, Inc."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-01T21:04:24.000Z","date":"2017-05-30","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These options were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc."}],"balance_after":2000,"derivative":{"exercise_price":4.38,"exercise_date":"2018-05-30","expiration_date":"2027-05-30","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001571049-17-005584","document":"t1701732_x2-f4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1130166/000157104917005584/t1701732_x2-f4.xml","form_type":"4"}},{"id":4340649,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-01T20:48:56.000Z","date":"2017-04-28","kind":"grant","acquired":true,"shares":2857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 1/12th of the shares subject to the option for each month of service following the date of grant."}],"balance_after":2857,"derivative":{"exercise_price":15.61,"expiration_date":"2027-04-28","underlying":"Common Stock","underlying_shares":2857},"source":{"system":"sec-edgar","filing":"0001127602-17-016055","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217016055/form4.xml","form_type":"4"}},{"id":4340648,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":41451,"kind":"person","name":"BARKER SAM L","position":1,"cik":"0001226877","reported_name":"BARKER SAM L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-01T20:48:56.000Z","date":"2017-04-28","kind":"grant","acquired":true,"shares":1281,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24623,"source":{"system":"sec-edgar","filing":"0001127602-17-016055","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217016055/form4.xml","form_type":"4"}}]}